Direct-Acting Antivirals and Host-Targeting Agents Against the Hepatitis a Virus

Journal of Clinical and Translational Hepatology
doi 10.14218/jcth.2015.00016
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Xia & He Publishing

Related search

Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe

Hepatology
MedicineHepatology
2016English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2012English

Pgi13 - Real-Life Budget Impact of Direct-Acting Antivirals Against Hepatitis C Virus in an Spanish Public Hospital Pharmacy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology
Hepatology
2017English

Two Cases of Hepatocellular Carcinoma Occurring Immediately After Direct-Acting Antiviral Agents Against Hepatitis C Virus

Internal Medicine
Internal MedicineMedicine
2019English

Coinfection With Hepatitis B and Hepatitis C Virus: New Insights of Treatment in the Era of Direct Acting Antivirals.

International Journal of Advanced Research
2017English

Concomitant Use of Direct-Acting Antivirals and Chemotherapy in Hepatitis C Virus-Infected Patients With Cancer

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Hepatitis C Virus Re-Treatment in the Era of Direct-Acting Antivirals: Projections in the USA

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy